Analytics
Also: Decentralized clinical trial startup Curebase names vice president of clinical operations, and digital opioid use disorder-treatment company Ophelia hires a chief technology officer.
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.
One of the projects will develop a digital navigator to support people with chronic conditions.
It will be used to accelerate collaborations with pharmaceutical firms.
It will use its latest funds for its global expansion.
Also, scientists from the University of South Australia have developed tiny fibre sensors for remote patient monitoring.
The company also has pending approvals for the device in Australia and Thailand.
The layoffs represent 13% of the AI-backed genomic and clinical data company's workforce.
Also, engineers from the University of Hong Kong have come up with a tiny biosensing platform for personalised health monitoring.
The startup's tool records and transcribes conversations between providers and patients, and then organizes relevant information about health conditions, symptoms and next steps.